Lyme disease does not directly change urine color through the bacteria themselves, but the infection and its treatment can indirectly affect urine in several ways. The most documented link is with certain antibiotics used to treat Lyme, particularly rifampin, which reliably turns urine orange-red. Severe Lyme complications causing kidney involvement are rare but can alter urine appearance. Dehydration from fever, and a co-infection called babesiosis that causes red blood cell destruction, are other indirect routes. Most people with Lyme disease have normal urine color.

Lyme disease is a tick-borne infection caused by Borrelia burgdorferi in North America and related Borrelia species in Europe and Asia. The question of whether it changes urine color comes up often, and the honest answer requires separating direct effects of the infection from indirect effects of treatment, fever, and co-infections. This explainer walks through the mechanisms, the numbers behind them, the edge cases clinicians watch for, and the practical steps that follow from each.

The direct mechanism and why it mostly fails

Borrelia burgdorferi does not produce pigments that the kidneys excrete in amounts visible to the eye. The organism disseminates through blood and tissue during early infection, but it does not typically colonize the urinary tract in a way that discolors urine. This is a key difference from urinary tract infections caused by bacteria such as E. coli, where inflammation and sometimes blood in the urine change its appearance.

The kidneys filter roughly 180 liters of plasma daily in a healthy adult and produce about 1 to 2 liters of urine. For urine color to shift visibly, a substance must reach a concentration the eye can detect, roughly on the order of milligrams per liter for strong pigments. Borrelia does not generate such a pigment. There is no established mechanism by which the spirochete itself tints urine.

What the infection can do is trigger systemic inflammation and fever. Fever raises insensible fluid losses through sweating and respiration, and reduced oral intake during illness compounds the deficit. Concentrated urine appears darker yellow to amber because urochrome, the normal yellow pigment derived from hemoglobin breakdown, becomes more concentrated. This is an indirect, nonspecific effect that any febrile illness can produce.

A rare but serious route exists through kidney involvement. Lyme disease can, in uncommon cases, cause glomerulonephritis, an inflammation of the kidney's filtering units. When the glomeruli leak, urine may appear frothy from protein or reddish from blood. These presentations are documented but uncommon, and they typically occur alongside other systemic signs rather than as an isolated finding.

What the treatment does to urine color

The most reliable and best-documented link between Lyme disease care and urine color is a medication effect. Rifampin, an antibiotic sometimes used in combination regimens for Lyme disease, is a potent pigment. It turns urine, sweat, and tears orange-red, and it can permanently stain soft contact lenses. This effect is expected, harmless, and resolves after the drug clears.

Rifampin's color change comes from the drug's own chemical structure. It is a red-brown compound that the liver metabolizes and the kidneys excrete. The color appears within hours of a dose and can last a day or more after the last dose. Patients are routinely counseled about this so they do not mistake it for blood.

Other antibiotics used for Lyme, including doxycycline, amoxicillin, and cefuroxime, do not typically discolor urine. Doxycycline can rarely cause photosensitivity and esophageal irritation, but orange urine is not a recognized effect. This distinction matters because people often assume any antibiotic will change urine color, and that assumption can cause unnecessary alarm or, worse, lead them to stop a needed medication.

Quantified context: how often and how much

Precise population-level statistics on urine color changes in Lyme disease are not well established, because urine color is not a routinely tracked outcome in Lyme surveillance. What can be stated with confidence is the mechanism-level certainty: rifampin discoloration is near-universal among people taking it, while direct Borrelia pigmentation is not a recognized phenomenon.

Cause Mechanism Typical urine appearance How common in Lyme context
Rifampin Drug pigment excretion Orange to red-orange Expected with every dose
Dehydration from fever Urochrome concentration Dark yellow to amber Common with any febrile illness
Babesiosis co-infection Hemolysis releases hemoglobin Red, brown, or cola-colored Uncommon, depends on co-infection
Glomerulonephritis from Lyme Blood and protein leakage Reddish or frothy Rare
Doxycycline or amoxicillin No recognized pigment effect Normal Not expected

The table makes the hierarchy clear. The most common cause is a drug, not the infection. The most dangerous cause is a co-infection or kidney complication, and both are uncommon. The most likely cause in a person with fever is simple dehydration.

Edge cases that change the picture

Babesiosis deserves separate attention. It is a malaria-like parasite transmitted by the same Ixodes ticks that carry Borrelia, and co-infection occurs in a meaningful minority of patients in endemic regions. Babesia infects red blood cells and destroys them, releasing hemoglobin into plasma. When hemoglobin exceeds the kidney's reabsorption capacity, it spills into urine and produces a red to dark brown color. This is a medical emergency, not a benign side effect.

Another edge case is hematuria from urinary tract infection or kidney stones occurring coincidentally during Lyme treatment. Lyme does not protect against other conditions, and a person with Lyme can develop a UTI or pass a stone. The presence of Lyme should not anchor a clinician away from evaluating new red urine for these common causes.

The counterintuitive detail worth flagging: dark urine in a patient being treated for Lyme is more often a sign of dehydration or a drug effect than of worsening infection. Clinicians are trained to consider the mundane explanations first. That said, the mundane explanation must be confirmed, not assumed, especially when fever, back pain, or jaundice accompany the color change.

Common misconceptions and what the evidence says

One persistent misconception is that Lyme disease "turns urine dark" as a diagnostic sign. No major public health body lists urine color as a diagnostic criterion for Lyme disease. Diagnosis rests on clinical presentation, particularly the erythema migrans rash, combined with serologic testing in appropriate settings. Urine color adds no diagnostic value.

A second misconception is that a color change proves herxheimer reaction, a temporary worsening of symptoms sometimes reported after starting antibiotics. There is no established mechanism by which a herxheimer reaction would produce a specific urine color. Attributing orange urine to a herxheimer reaction when the patient is taking rifampin confuses a known drug effect with an unproven phenomenon.

A third misconception is that clear urine means the infection has cleared or that dark urine means it is active. Urine color reflects hydration and, occasionally, drug or disease effects. It does not track Borrelia burden. No evidence supports using urine color to monitor Lyme disease response.

Practical actions and red-flag thresholds

For most people with Lyme disease, the practical steps are straightforward and reassuring.

If you are taking rifampin and urine turns orange-red, expect it. Do not stop the medication without contacting your prescriber. If urine is dark yellow to amber and you have fever or poor intake, increase oral fluids unless a clinician has restricted them for heart or kidney reasons. If urine is red, brown, or cola-colored, seek medical evaluation the same day. Do not wait to see whether it resolves. If dark urine comes with yellowing of the eyes or skin, right-upper abdominal pain, or pale stools, seek urgent care. These suggest liver involvement. If you have been in a tick-endemic area and have fever with dark urine, tell the clinician about tick exposure and ask whether babesiosis testing is warranted.

A useful threshold for hydration is urine that is pale yellow to light amber. Urine that is consistently dark amber despite drinking fluids, or that stays dark after rehydration, warrants a clinician's review. Red, brown, or tea-colored urine is never normal and always warrants prompt evaluation.

Limitations and what cannot be concluded

The evidence base for urine color as a Lyme-related sign is thin, and this explainer cannot claim more than the mechanisms support. There is no large cohort study quantifying how often urine color changes in Lyme disease, and such a study would be difficult because urine color is confounded by hydration, diet, medications, and co-infections. Diet alone, including beets, blackberries, and certain food dyes, can turn urine red or pink.

Beets are a classic example. Beeturia, the passage of red or pink urine after eating beets, affects a variable share of people depending on gut bacteria and iron status. It is benign and often mistaken for blood. A clinician evaluating red urine will typically ask about diet before ordering tests.

Another limitation is that this explainer cannot address individual cases. A person with Lyme disease and dark urine needs an assessment that includes their medications, fluid intake, other symptoms, and laboratory tests. The mechanisms described here are general. They are not a substitute for evaluation, and they should not be used to rule out serious causes.

What can be concluded with confidence is this: the spirochete itself is not a recognized direct cause of urine discoloration, rifampin is a well-documented and expected cause, dehydration is a common and benign cause, and hemolysis from babesiosis or kidney involvement from Lyme are uncommon but serious causes that require prompt attention. Sorting among these is a clinical task, and the color itself is a prompt to think, not a diagnosis.